SCHEMBL6583915

SCHEMBL6583915

c1cc2c(c(N3CCC(NC4Cc5cc6c(cc5C4)OCO6)CC3)c1)OCCC2

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.45
ADRA1D P25100 1/20 0.42
ADRA1A P35348 1/20 0.42
ADRA1B P35368 1/20 0.42
DRD2 P14416 3/20 0.37
HTR2A P28223 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
PMP22 Q01453 1/20 0.37
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
DRD1 P21728 1/20 0.36
KIF18A Q8NI77 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6585910 0.88 HTR1A (0.47) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL7480273 0.86 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL7483007 0.86 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL7480063 0.86 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL7480058 0.86 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL6581590 0.85 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL6584899 0.85 HTR1A (0.46) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL6582162 0.85 HTR1A (0.57) HTR1AADRA1DADRA1AADRA1BDRD2
SCHEMBL6584486 0.82 NPY1R (0.44) HTR1ADRD2HTR2ADRD1
SCHEMBL6582184 0.81 HTR1A (0.40) HTR1AADRA1DADRA1AADRA1BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861837-A1 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1998-09-02 EP claimed
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 WO disclosed
EP-0861837-B1 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2004-04-28 EP disclosed
US-5968954-A EXHIBIT SELECTIVE BINDING AFFINITY FOR 5-HYDROXYTRYPTAMINE RECEPTORS ADIR ET COMPAGNIE (FR) 1999-10-19 US disclosed
EP-0861837-A1 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1998-09-02 EP disclosed